These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6650699)

  • 1. The use of tacrine for tardive dyskinesia.
    Ingram NA; Newgreen DB
    Am J Psychiatry; 1983 Dec; 140(12):1629-31. PubMed ID: 6650699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial experience with the administration of 7-methoxyacrine to patients with psychological disorders].
    Zapletálek M; Hanus H; Fusek J; Hrdina V
    Cesk Psychiatr; 1989 Jun; 85(3):155-8. PubMed ID: 2766394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of tardive dyskinesia by single and repeated application of 7-methoxytacrin.
    Hanus H; Tůtma I; Zapletálek M; Fusek J; Hrdina V
    Homeost Health Dis; 1991; 33(5-6):301-4. PubMed ID: 18265509
    [No Abstract]   [Full Text] [Related]  

  • 4. First experience with the application of 7-methoxytacrine to psychiatric patients.
    Zapletálek M; Hanus H; Fusek J; Hrdina V
    Act Nerv Super (Praha); 1989 Dec; 31(4):305-6. PubMed ID: 2576923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of tardive dyskinesias with 7-methoxycrine. II].
    Hanus H; Tůma I; Fusek J; Patocka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1993; 36(1-2):47-53. PubMed ID: 8191252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of tardive dyskinesias with 7-methoxytacrine. I].
    Hanus H; Tůma I; Fusek J; Patocka J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1993; 36(1-2):37-45. PubMed ID: 8191251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.
    Richardson MA; Bevans ML; Read LL; Chao HM; Clelland JD; Suckow RF; Maher TJ; Citrome L
    Am J Psychiatry; 2003 Jun; 160(6):1117-24. PubMed ID: 12777270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
    Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
    Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
    Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrine in Alzheimer's disease.
    Davies B; Andrewes D; Stargatt R; Ames D; Tuckwell V; Davis S
    Lancet; 1989 Jul; 2(8655):163-4. PubMed ID: 2567933
    [No Abstract]   [Full Text] [Related]  

  • 12. Metoclopramide treatment of tardive dyskinesia.
    Karp JM; Perkel MS; Hersh T; McKinney AS
    JAMA; 1981 Oct 23-30; 246(17):1934-5. PubMed ID: 7288971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type.
    N Engl J Med; 1987 Jun; 316(25):1603-5. PubMed ID: 3587295
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of tardive dyskinesia with vitamin E.
    Egan MF; Hyde TM; Albers GW; Elkashef A; Alexander RC; Reeve A; Blum A; Saenz RE; Wyatt RJ
    Am J Psychiatry; 1992 Jun; 149(6):773-7. PubMed ID: 1350428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
    Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C
    Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol.
    Ondo WG; Hanna PA; Jankovic J
    Am J Psychiatry; 1999 Aug; 156(8):1279-81. PubMed ID: 10450276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
    Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J
    J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E in the treatment of tardive dyskinesia: a double-blind placebo-controlled study.
    Shriqui CL; Bradwejn J; Annable L; Jones BD
    Am J Psychiatry; 1992 Mar; 149(3):391-3. PubMed ID: 1346951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.